|
|
|
Volumn 31, Issue 5, 2009, Pages 321-323
|
|
[Some problems facing the molecular targeting therapy for colorectal cancer].
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
BEVACIZUMAB;
CETUXIMAB;
EPIDERMAL GROWTH FACTOR RECEPTOR;
MONOCLONAL ANTIBODY;
RAS PROTEIN;
VASCULOTROPIN A;
COLORECTAL TUMOR;
DRUG ANTAGONISM;
DRUG DELIVERY SYSTEM;
GENETICS;
HUMAN;
METABOLISM;
METHODOLOGY;
MUTATION;
REVIEW;
ANTIBODIES, MONOCLONAL;
ANTINEOPLASTIC AGENTS;
COLORECTAL NEOPLASMS;
DRUG DELIVERY SYSTEMS;
HUMANS;
MUTATION;
RAS PROTEINS;
RECEPTOR, EPIDERMAL GROWTH FACTOR;
VASCULAR ENDOTHELIAL GROWTH FACTOR A;
|
|
EID: 79952115877
PISSN: 02533766
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (1)
|
|
References (0)
|
